A study shed light on the side effects of mental health, narrowing down those who are genetically more vulnerable.

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

A new study reveals a potential link between popular weight loss drugs like Ozempic and an increased risk of depression and ...

New study finds potential link between GLP1 agonists and depression, urging further investigation into patient safety.

Vision loss, thyroid tumours, kidney problems, gallbladder issues and pancreatitis are some of the concerning side effects ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Initially developed to manage blood sugar levels in diabetic patients, GLP-1 agonists have gained popularity for their weight-reducing effects.

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely used in blockbuster ...

Fixed and flexible doses of tavapadon significantly improved motor function compared with placebo in patients with ...

A new study raises mental health concerns about popular weight loss drugs like Ozempic and Mounjaro. These GLP-1 agonists, ...